Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign

• Melissa L. Sykes ,

  Contributed equally to this work with: Melissa L. Sykes, Jonathan B. Baell

  Affiliation Discovery Biology, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, Queensland, Australia

  ⨯
• Jonathan B. Baell ,

  Contributed equally to this work with: Melissa L. Sykes, Jonathan B. Baell

  Affiliations The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia, Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia

  ⨯
• Marcel Kaiser,

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯
• Eric Chatelain,

  Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

  ⨯
• Sarah R. Moawad,

  Affiliations The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia

  ⨯
• Danny Ganame,

  Affiliations The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia

  ⨯
• Jean-Robert Ioset,

  Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

  ⨯
• Vicky M. Avery

  * E-mail: v.avery@griffith.edu.au

  Affiliation Discovery Biology, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, Queensland, Australia

  ⨯